The Enterprise Value as of December 2024 (TTM) for Cabaletta Bio, Inc. (CABA) is -40766966.00

According to Cabaletta Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -40766966.00. This represents a change of -109.22% compared to the average of 442.30M of the last 4 quarters.

Cabaletta Bio, Inc. (CABA) Historical Enterprise Value (quarterly & annually)

How has CABA Enterprise Value performed in the past?

The mean historical Enterprise Value of Cabaletta Bio, Inc. over the last ten years is 242.12M. The current -40766966.00 Enterprise Value has changed -1783.74% with respect to the historical average. Over the past ten years (40 quarters), CABA's Enterprise Value was at its highest in in the December 2023 quarter at 820.46M. The Enterprise Value was at its lowest in in the September 2022 quarter at -42303903.25.

Cabaletta Bio, Inc. (CABA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cabaletta Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cabaletta Bio, Inc. (CABA) Average Enterprise Value

How has CABA Enterprise Value performed in the past?

The current Enterprise Value of Cabaletta Bio, Inc. (CABA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cabaletta Bio, Inc. (CABA) Enterprise Value vs. Peers

How is CABA’s Enterprise Value compared to its peers?

Cabaletta Bio, Inc.’s Enterprise Value is less than TCR2 Therapeutics Inc. (0), less than Revolution Medicines, Inc. (79.12M), less than Black Diamond Therapeutics, Inc. (7.86B), less than Atreca, Inc. (124.11M), less than Passage Bio, Inc. (-8620212.00), less than 89bio, Inc. (34.29M), less than Madrigal Pharmaceuticals, Inc. (878.58M), less than Pliant Therapeutics, Inc. (6.64B), less than Arcellx, Inc. (792.38M), less than Stoke Therapeutics, Inc. (4.01B), less than Harpoon Therapeutics, Inc. (461.40M), less than Alector, Inc. (861.85M), less than Larimar Therapeutics, Inc. (183.55M), less than Homology Medicines, Inc. (226.48M), greater than Day One Biopharmaceuticals, Inc. (-103303255.00), less than null (852.53M),

Build a custom stock screener for Cabaletta Bio, Inc. (CABA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabaletta Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cabaletta Bio, Inc. (CABA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cabaletta Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.